Clinical Trials Logo

Filter by:
NCT ID: NCT06125080 Recruiting - Clinical trials for TNBC - Triple-Negative Breast Cancer

The Efficacy and Safety of Utidelone Plus Tirelizumab and Bevacizumab for Advanced or Metastatic Triple-negative Breast Cancer (UTILIZABLE) :Single-arm, Prospective, Open Clinical Study

UTILIZABLE
Start date: October 30, 2023
Phase: Phase 2
Study type: Interventional

This is a multicenter, open-label, single-arm clinical study designed to evaluate the safety and efficacy of Utidelone plus Tirelizumab and Bevacizumab for advanced or metastatic triple-negative breast cancer (TNBC).

NCT ID: NCT06125041 Recruiting - Clinical trials for Extensive Small Cell Lung Cancer

Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC

Start date: October 30, 2023
Phase: Phase 2
Study type: Interventional

To observe the efficacy and safety of adebelizumab combined with chemotherapy and sequential adebelizumab combined with radiotherapy in the treatment of newly diagnosed extensive small cell lung cancer.

NCT ID: NCT06124963 Recruiting - Clinical trials for Gastric Type Adenocarcinoma (GAS) With STK11 Mutation

A Study of WX390 Combined With Toripalimab in Patients With Advanced Gastric-type Endocervical Adenocarcinoma With STK11 Mutations

Start date: August 25, 2023
Phase: Phase 2
Study type: Interventional

The goal of this clinical trial is to evaluate the safety and preliminary efficacy of WX390 combined with Toripalimab in patients with advanced Gastric-type Endocervical Adenocarcinoma with STK11 mutations. The main questions it aims to answer are: - Pharmacokinetic (PK) characteristics of WX390 combined with Toripalimab treatment. - Safety and preliminary in combined therapy. Participants will be treated with WX390 orally and Toripalimab intravenously, and follow the efficacy and safety evaluation according to the protocol.

NCT ID: NCT06124768 Recruiting - Clinical trials for Deep Vein Thrombosis

Comparison Of Percutaneous Mechanical Thrombectomy With Different Access in Treatment of Acute Deep Venous Thrombosis

Start date: January 1, 2021
Phase:
Study type: Observational

The study aims to compare the modified approach through ipsilateral deep calf venous access of contralateral femoral venous access with the traditional approach through ipsilateral popliteal venous access for mixed type deep venous thrombosis (DVT), and determine whether it can achieve similar therapeutic effects as central type DVT.

NCT ID: NCT06124755 Not yet recruiting - Clinical trials for Peripheral Arterial Disease

The Efficacy of Heparin-boned Viabahn Endoprosthesis and Paclitaxel-coated Balloons for Complex Femoropopliteal Lesions

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the effectiveness of the Viabahn endoprosthesis for treating long femoropopliteal lesions (stenosis ≥ 25cm, occlusion ≥ 15cm) or recurrent in-stent restenosis compared to drug-coated balloons (DCB) with or without a bailout bare nitinol stent.

NCT ID: NCT06124417 Completed - Clinical trials for Adverse Reaction to Drug

Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression

Start date: January 10, 2022
Phase: Phase 4
Study type: Interventional

Depression is a common mental disorder in patients undergoing maintenance hemodialysis (MHD), which increases the risk of cardiovascular events, hospitalization rates, and mortality, but has not received enough attention from patients and medical staff. Sertraline is a selective serotonin reuptake inhibitor with fewer adverse reactions and higher safety compared to other antidepressants. This study aims to investigate the efficacy and safety of sertraline in patients undergoing MHD with depression. This study used a randomized controlled design and evaluated the depression status of the patients using the Hamilton Depression Scale (HAMD). MHD patients with comorbid depression were recruited and divided into the treatment group and the control group. The treatment group received sertraline for antidepressant therapy, while the control group did not receive any antidepressant medication. To investigate the efficacy and safety of sertraline before and after intervention.

NCT ID: NCT06124404 Completed - Clinical trials for Mechanically Ventilated Patients

Step 1 of A Two-step Trial to Evaluate the Effectiveness and Safety of Remimazolam Besylate for Sedation in ICU Patients

Start date: April 8, 2022
Phase: Phase 2
Study type: Interventional

This is a Phase II, dose-escalation clinical trial conducted in mechanically ventilated patients receiving sedation no longer than 24 hours. The efficacy, safety, and pharmacokinetics of remimazolam besylate were evaluated using a randomized, single-blind design.

NCT ID: NCT06124391 Recruiting - Clinical trials for Polycystic Ovary Syndrome

Novel Subtypes of Polycystic Ovary Syndrome

Start date: January 1, 2021
Phase:
Study type: Observational

To classify subtypes of Polycystic Ovary Syndrome (PCOS) using machine-learning algorithms, and compare the reproductive and metabolic characteristics and IVF outcomes across these identified subtypes.

NCT ID: NCT06124378 Recruiting - Colonic Neoplasms Clinical Trials

Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer

Start date: November 13, 2023
Phase: Phase 2
Study type: Interventional

This study aims to elucidate the effects of neoadjuvant Tislelizumab combined with chemotherapy in locally advanced Microsatellite Stable (MSS) colon cancer.

NCT ID: NCT06124170 Completed - Knee Osteoarthritis Clinical Trials

Improved Pain Management in Knee Osteoarthritis-related Surgeries

Start date: March 1, 2016
Phase:
Study type: Observational

In recent years, pain management coordinated with enhanced recovery after surgery (ERAS) has been widely applied and rapidly developed in orthopedics, showing promising prospects. Since 2016, our hospital has used a series of continuously improved pain management schemes for patients with knee OA who underwent total knee arthroplasty (TKA), unicompartmental knee arthroplasty (UKA), and high tibial osteotomy (HTO). Here, we retrospectively analyze these patients' clinical data to compare the effects of different pain intervention measures during the perioperative period on postoperative pain, functional exercise, hospital stay, and prognosis of the three surgical methods in an attempt to provide a feasible solution for pain management of these patients.